Senate Bill 535, introduced by Senator K. Bogner on April 4, 2025, aims to revise Montana's laws regarding experimental treatments by establishing a licensing framework for experimental treatment centers. This legislation seeks to enhance patient access to innovative therapies while ensuring safety and regulatory oversight.

The bill outlines key provisions, including the requirement for centers to obtain a license before operation, with applications needing to detail the center's management and location. The Montana Department of Public Health and Human Services will be tasked with approving or denying applications within 90 days and developing administrative rules that set minimum operational standards, oversight mechanisms, and facility inspections.

One of the significant aspects of SB 535 is its amendment to the existing Right to Try Act, which allows terminally ill patients to access experimental treatments not yet fully approved by the FDA. The proposed changes aim to clarify definitions and expand the scope of eligible treatments, potentially increasing options for patients facing dire health situations.

The bill has sparked notable debate among lawmakers and healthcare advocates. Proponents argue that it will facilitate faster access to potentially life-saving treatments for patients who have exhausted conventional options. Critics, however, express concerns about the adequacy of oversight and the potential for exploitation of vulnerable patients in the pursuit of unproven therapies.

Economically, the establishment of licensed centers could stimulate growth in Montana's healthcare sector, attracting investment and innovation. However, the implications for patient safety and ethical considerations surrounding experimental treatments remain contentious.

As the legislative process unfolds, SB 535's future will depend on further discussions and potential amendments. If passed, it could significantly reshape the landscape of experimental treatment access in Montana, balancing the need for innovation with the imperative of patient protection.